Sunday, July 20, 2014

10 Best Life Sciences Stocks For 2014

With shares of�Corning Inc.�(NYSE:GLW) trading at around $16.35, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

C = Catalyst for the Stock�� Movement

Corning has been making new 52-week highs as of late, but is this trend sustainable? In this stock market environment, anything is possible. However, that doesn�� mean all moves are justifiable.

Corning Incorporated produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.

Corning has a diverse revenue base. There is currently high demand for tablets and smartphones, Gorilla Glass has received many positive reviews, Q1 estimates were recently beat, there have been cost and efficiency improvements, revenue has increased for three consecutive years, and the stock is at a good valuation, trading at 14 times earnings, while the industry trades at 19 times earnings. However, when you look at the breakdown for the last quarter, there is good reason for caution. The only segment that showed improvement was Life Sciences. Corning is confident in future growth, but that doesn�� mean confidence will lead to actual results.

Hot Prefered Stocks To Own For 2015: Maxygen Inc.(MAXY)

Maxygen, Inc., a biopharmaceutical company, focuses on developing improved versions of protein drugs in North America and Europe. The company utilizes its MolecularBreeding directed evolution technology platform, along with ancillary technologies, and protein modification expertise to pursue the creation of biosuperior proteins. It engages in the discovery, research, and development of MAXY-G34 product candidates for the treatment of chemotherapy-induced neutropenia. The company was founded in 1996 and is headquartered in Redwood, California.

Advisors' Opinion:
  • [By Geoff Gannon]

    1. Steel Excel (SXCL)
    2. FormFactor (FORM)
    3. Imation (IMN)
    4. Tuesday Morning (TUES)
    5. Pacific Biosciences (PACB)
    6. Maxygen (MAXY)
    7. Westell (WSTL)
    8. Volt Information Sciences (VISI)
    9. Yasheng Group (YHGG)

10 Best Life Sciences Stocks For 2014: iSoftStone Holdings Limited(ISS)

iSoftStone Holdings Limited provides various information technology (IT) services and solutions in the Greater China and internationally. It offers an integrated suite of IT services and solutions, including consulting and solution services, IT services, and business process outsourcing (BPO) services. The company provides a range of consulting services for an overall engagement or discrete consulting services in conjunction with other services. It also develops industry-specific solutions, including treasury management, cash management, property and casualty insurance core, financial holding company business analysis, trust company core, and banking risk management solutions for banking, financial services, and insurance industries; supply chain management, enterprise information portals, business intelligence, business process integration, and management and e-commerce solutions for energy, transportation, and public sectors; mobile and embedded technology, next generati on platforms, business intelligence functionality, and network security products for the communications industry. In addition, the company offers various IT services consisting of application development and maintenance, research and development, and infrastructure and software services. Further, it provides a range of BPO services, such as securities trade processing services for the investment banking industry; digitization and archiving of policyholder information, as well as account processing and customer service for insurance industry; and cross-industry BPO services comprising finance and accounting, customer care, and human resources. The company was founded in 2001 and is headquartered in Beijing, the People?s Republic of China.

Advisors' Opinion:
  • [By Seth Jayson]

    iSoftStone Holdings (NYSE: ISS  ) reported earnings on May 17. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), iSoftStone Holdings beat expectations on revenues and beat expectations on earnings per share.

10 Best Life Sciences Stocks For 2014: Koninklijke Philips Electronics N.V.(PHG)

Koninklijke Philips Electronics N.V. engages in the healthcare, consumer lifestyle, and lighting product businesses worldwide. The company offers screening, diagnosis, treatment, monitoring, and health management services in cardio-pulmonary, oncology, and women?s health areas. Its healthcare products and solutions include X-rays, computed tomography, magnetic resonance, nuclear medicine, and ultrasound imaging equipment; and cardiology informatics and diagnostic electrocardiography, radiology information systems, picture archiving and communication systems, patient monitoring and clinical informatics, perinatal care, and therapeutic care systems. The company?s healthcare products and solutions also consist of sleep management and respiratory care, medical alert, remote cardiac, and remote patient management services. In addition, it offers consultancy, site planning and project management, clinical, education, equipment financing, asset management, and equipment mainten ance and repair services. The company?s consumer lifestyle products and solutions comprise mother and childcare, oral healthcare, male grooming, skincare, and beauty products; coffee, floor and garment care, kitchen, water and air, and beverage appliances; and communication and control, audio and multimedia, speech processing, headphones and accessories, and home cinema and video products. Its lighting solutions include lamps, including incandescent, halogens, fluorescent, high-intensity discharge, and LED lamps; consumer luminaires for functional, decorative, lifestyle, and scene-setting applications; professional luminaires for city beautification, and road, sports, shop/hospitality, and industry lighting applications; systems and controls, that include electronic and electromagnetic gears, controls, modules, and drivers; automotive lighting, such as car headlights, car signaling, and interior; and packaged LEDs. The company was founded in 1891 and is headquartered in Ams terdam, the Netherlands.

Advisors' Opinion:
  • [By Monica Gerson]

    Koninklijke Philips NV (NYSE: PHG) fell 5.98% to $32.52 after the company reported a drop in its Q1 profit.

    Xerox (NYSE: XRX) dropped 2.96% to $11.13 after the company reported its Q1 earnings of $0.27 per share on revenue of $5.12 billion and lowered its FY14 earnings outlook.

  • [By Rich Smith]

    The Department of Defense awarded Philips (NYSE: PHG  ) Healthcare Informatics an $88.5 million-ceiling value, firm-fixed-price contract for the supply of a digital imaging network-picture archive�system. In so doing, it made progress on a project that's been in the works for 16 years.

  • [By Keith Speights]

    On the medical equipment front, GE Healthcare has a handful of major rivals. Philips (NYSE: PHG  ) and Siemens (NYSE: SI  ) stand out as two of the leading competitors. Both, like GE, are conglomerates that boast large health care business segments. Both Philips and Siemens market many of the same types of medical imaging equipment that GE does. �

10 Best Life Sciences Stocks For 2014: Helen of Troy Limited(HELE)

Helen of Troy Limited, together with its subsidiaries, engages in the design, development, import, marketing, and distribution of brand-name consumer products primarily in the United States and Canada, as well as in Europe, Asia, and Latin America. It operates in three segments: Personal Care, Housewares, and Healthcare/Home Environment. The Personal Care segment offers hair dryers, straighteners, curling irons, hair setters, shavers, mirrors, hot air brushes, home hair clippers and trimmers, paraffin baths, massage cushions, footbaths, body massagers, brushes, combs, hair accessories, liquid and aerosol hair styling products, men?s fragrances, men?s and women?s antiperspirants and deodorants, liquid and bar soaps, shampoos, conditioners, hair treatments, foot powder, body powder, and skin care products. The Housewares segment provides kitchen tools, cutlery, bar and wine accessories, household cleaning tools, food storage containers, tea kettles, trash cans, storage an d organization products, hand tools, gardening tools, kitchen mitts and trivets, barbeque tools, and rechargeable lighting products, as well as baby and toddler care products, including convertible high chair. The Healthcare/Home Environment segment offers humidifiers, de-humidifiers, vaporizers, thermometers, air purifiers, fans, portable heaters, heating pads, and electronic mosquito traps. The company sells its products primarily through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, catalogs, grocery stores, specialty stores, beauty supply retailers, e-commerce retailers, wholesalers, and various types of distributors, as well as directly online to end user consumers. Helen of Troy Limited was founded in 1968 and is based in Hamilton, Bermuda.

Advisors' Opinion:
  • [By Monica Gerson]

    Helen of Troy (NASDAQ: HELE) is estimated to post its Q2 earnings at $0.72 per share on revenue of $292.15 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Canadian Value]

    NEW YORK, Feb. 4, 2014 /PRNewswire/ -- Sachem Head Capital Management today sent a letter to the Board of Directors of leading consumer goods company Helen of Troy Limited (HELE). In the letter, Sachem Head outlines its belief that Helen of Troy shares are materially undervalued, highlighting the Board's apparent unwillingness to respond to recent inquiries regarding potential strategic combinations, and recommending actions for the Board of Directors to undertake to maximize value for the shareholders, including a thorough and legitimate review of strategic alternatives.

  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    Helen of Troy Ltd.(HELE) said it expects to buy back about $246 million of its shares through a Dutch auction tender offer that allowed the personal-care company to repurchase up to $300 million in stock. The company, whose products include OXO kitchen tools and Brut After Shave, said it expects to acquire about 3.7 million shares at $66.50 a share, the high end of its offering range.

  • [By Wallace Witkowski]

    Helen of Troy Ltd (HELE) �shares rose 1.3% to $49.20 on light volume after reporting third-quarter earnings of $1.16 a share on revenue of $380.7 million. Analysts had forecast earnings of $1.09 a share on revenue of $378.9 million.

10 Best Life Sciences Stocks For 2014: Ceragon Networks Ltd.(CRNT)

Ceragon Networks Ltd. offers wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services. Its wireless backhaul solutions use microwave technology to transfer large amounts of telecommunication traffic between base stations and the core of the service provider?s network. The company offers Internet protocol (IP) based FibeAir IP-10E/IP-MAX2, a high-capacity Ethernet that is used in wireless backhaul for carriers, private networks, and metro area networks; FibeAir IP-10G/IP-MAX2, a high-capacity multi-service, which is used in wireless backhaul for carriers and private networks; FibeAir 2000/4800, an unlicensed multi-service for private networks and business access; FibeAir/1500R, a high-capacity SDH/SONET for wireless backhaul and metro area networks; and FibeAir 3200T, a high-capacity circuit-switched TDM for wireless backhaul and long distance networks. It also provides advanced pure IP/Ethernet solu tions to wireless broadband service providers, as well as to businesses and public institutions that operate their own private communications networks. In addition, the company offers turnkey project services, including network and radio planning, site survey, solutions development, installation, maintenance, and training services. It sells its products through various channels, including direct sales, original equipment manufacturers, resellers, distributors, and system integrators in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company was formerly known as Giganet Ltd. and changed its name to Ceragon Networks Ltd. in September 2000. Ceragon Networks Ltd. was founded in 1996 and is headquartered in Tel Aviv, Israel.

Advisors' Opinion:
  • [By Peter Graham]

    The third quarter 2014�earnings report for network communication platform maker�Ubiquiti Networks Inc (NASDAQ: UBNT), a peer of small cap stocks�Aviat Networks Inc (NASDAQ: AVNW), Ceragon Networks Ltd (NASDAQ: CRNT) and�DragonWave, Inc (NASDAQ: DRWI), is due out after the market closes on Thursday with shares already trending upwards as they closed 4.08% higher on Tuesday. Aside from the Ubiquiti Networks earnings report, it should be said that Aviat Networks Inc reported earnings yesterday after the market closed (shares were sinking hard in after hours trading); Ceragon Networks Ltd will report earnings before the market opens on Thursday; and DragonWave, Inc is scheduled to report after the market closes next Wednesday. So it�� a busy week for network communications stocks.

  • [By Vanina Egea]

    Looking forward, Telef贸nica Brasil is investing in technology and network expansion to further empower its competitive position. The firm is expanding its 3G network based on CDMA EV-DO and HSPA technologies, which provide a great advantage over its peers. Further, it expects to benefit from the growth opportunities in the 4G market. Consequently, it has signed a deal with Ceragon Networks Ltd. (CRNT) to deploy the superfast 4G network nationwide.

10 Best Life Sciences Stocks For 2014: Golden Minerals Co. (AUMN)

Golden Minerals Company engages in the mining, exploration, and development of mineral properties in Mexico and South America. It explores for silver and gold dor茅 bars, precipitates, lead, zinc, and pyrite concentrates. The company holds 100% interests in the Velarde帽a and Chicago precious metals mining operations that cover approximately 600 hectares located in the State of Durango, Mexico; and the Zacatecas silver and base metals project that consists of 195 concessions covering approximately 8,600 hectares in Mexico. It also owns interests in the El Quevar project that comprises 32 exploitation concessions covering approximately 55,000 hectares in the province of Salta, Argentina; and controls approximately 40 exploration properties that cover approximately 320,000 hectares located in the regions of Mexico and South America. The company was formerly known as Apex Silver Mines Limited and changed its name to Golden Minerals Company in March 2009 as a result of reorgan ization. Golden Minerals Company was founded in 1996 and is headquartered in Golden, Colorado.

Advisors' Opinion:
  • [By Zacks Investment Research]

    Headquartered in Golden, Colorado, Golden Minerals Company (AUMN) owns mining operations and precious metals exploration properties in Mexico and South America.

10 Best Life Sciences Stocks For 2014: Five Prime Therapeutics Inc (FPRX)

Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. Protein therapeutics is antibodies or drugs developed from extracellular proteins or protein fragments that block disease processes, including cancer and inflammatory diseases. The Company�� advanced product candidates include FP-1039/GSK3052230 (FP-1039), FPA008 and FPA144. FP-1039 is a protein therapeutic that traps and neutralizes cancer-promoting fibroblast growth factors (FGFs), involved in cancer cell proliferation and new blood vessel formation. FPA008 is an antibody that inhibits colony stimulating factor-1 receptor (CSF1R), and is being developed to treat patients with inflammatory diseases, including rheumatoid arthritis (RA). FPA144 is an antibody that inhibits FGF receptor 2b (FGFR2b), and is being developed to treat patients with gastric cancer and potentially other solid tumors.

FP-1039

FP-1039 is a protein therapeutic, which includes the extracellular part of FGFR1. FP-1039 acts as an inhibitor of FGFs, because the FGFR1 portion of the molecule binds to FGFs and prevents them from binding to FGFR1 on tumor and blood vessel cells. Because FGF proteins circulating in the blood are called ligands, FP-1039 is called a ligand trap. FP-1039 also includes a portion of an antibody called the Fc region. In preclinical testing, it observed inhibition of tumor growth with single-agent FP-1039, particularly in tumors withFGFR1 gene amplification, including squamous NSCLC and SCLC.

FPA008

FPA008 is an antibody that inhibits CSF1R and is being developed to treat patients with RA. FPA008 also has the potential to treat patients with other inflammatory diseases, including lupus nephritis, psoriatic arthritis, ankylosing spondylitis, fibrosis, inflammatory bowel disease and multiple sclerosis. These are chronic, incurable disorders with serious medical complications and disability for ! which better therapies with novel mechanisms of action are needed. FPA008 is an anti-CSF1R antibody, which it designed to block the ability of IL-34 and CSF1 to bind to and activate CSF1R. FPA008 reduces the numbers and activity of monocytes and macrophages that cause disease, and prevents the production and release of inflammatory factors. The Company and others has demonstrated that both IL-34 and CSF1 are present at increased levels in the inflamed joints of patients with RA.

FPA144

FPA144 is a monoclonal antibody directed against a form of FGFR2, or FGFR2b. When the FGFR2 gene is amplified by cancer cells, the FGFR2b protein is expressed at abnormally high levels on the tumor�� surface. This occurs in some patients with gastric and lower esophageal cancers. The tumor cells that have too much FGFR2b protein on their surface can be identified by special staining tests performed on the tumor. Because FGFR2b is the target for FPA144, patients��tumors can be screened for this protein, helping to identify the patients most likely to respond to FPA144 treatment.

Advisors' Opinion:
  • [By John Kell and Tess Stynes var popups = dojo.query(".socialByline .popC"); p]

    Among the companies with shares expected to actively trade in Monday’s session are Keurig Green Mountain Inc.(GMCR), JA Solar Holdings Co.(JASO) and Five Prime Therapeutics Inc.(FPRX)

  • [By Monica Gerson]

    Breaking news

    Alcoa (NYSE: AA) is investing US$13 million to expand its wheel manufacturing plant in Europe, to meet growing demand for its lightweight, durable, low-maintenance aluminum truck wheels. To read the full news, click here. L & L Energy (NASDAQ: LLEN) announced today that its Special Independent Committee has appointed Mr. Nicholas Chen, Managing Partner at Pamir Law Group, to replace Mr. Mark Bartlett. To read the full news, click here. Five Prime Therapeutics (NASDAQ: FPRX) and Bristol-Myers Squibb (NYSE: BMY) announced today that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime's proprietary target discovery platform. To read the full news, click here. First Solar (NASDAQ: FSLR) on Sunday announced the completion of the 1.3MW(DC) solar photovoltaic (PV) power plant at Kitakyushu-shi. Powered by First Solar FS Series 3 Black PV modules, the plant will generate approximately 1,400 MWh of clean and safe solar electricity per year. To read the full news, click here.

    Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

No comments:

Post a Comment